Live feed
Filing
SC 13G/A
SC 13G/A0001104659-17-008029·Ayala Pharmaceuticals, Inc.
Schedule 13G ownership disclosure
ADVAXIS INC
Security class unavailable · CUSIP: 007624208
Event date: 2016-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 690,074
- Percent of class
- 1.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-17-008029
- Form type
- SC 13G/A
- Filer
- Ayala Pharmaceuticals, Inc.
- CIK
- CIK 1100397
- Filed
- Feb 10, 2017
- Reporting period
- Dec 31, 2016
- Description
- Schedule 13G beneficial ownership